info@news-matic.com

details

CVS Caremark Expands Biosimilar Adoption Through Formulary Updates to Improve Affordability and Access

New changes expected to deliver significant client savings while maintaining rigorous clinical standards WOONSOCKET, R.I., May 5, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost...

Cookie Consent + Tracking